Evidence map›Paper›PMID 35893073›Full record

ArticleGenes2022

Genetic Profile of Left Ventricular Noncompaction Cardiomyopathy in Children-A Single Reference Center Experience.

Dorota Piekutowska-Abramczuk, Agata Paszkowska, Elżbieta Ciara, Kamila Frączak, Alicja Mirecka-Rola, Dorota Wicher, Agnieszka Pollak, Karolina Rutkowska, Jędrzej Sarnecki, Lidia Ziółkowska

Open access · goldAbstract read
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Dilated cardiomyopathy in patients with PRDM16 haploinsufficiency.Journal of molecular medicine (Berlin, Germany) · 2025
    Article
  5. Review
  6. Article
  7. MYH7 in cardiomyopathy and skeletal muscle myopathy.Molecular and cellular biochemistry · 2024
    Review
  8. Mechanisms of RBM20 Cardiomyopathy: Insights From Model Systems.Circulation. Genomic and precision medicine · 2024
    Review
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Dorota Piekutowska-AbramczukDepartment of Medical Genetics, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.ORCID 0000-0002-9786-3704
Agata PaszkowskaDepartment of Cardiology, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.
Elżbieta CiaraDepartment of Medical Genetics, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.ORCID 0000-0002-1065-7968
Kamila FrączakDepartment of Medical Genetics, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.
Alicja Mirecka-RolaDepartment of Cardiology, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.
Dorota WicherDepartment of Medical Genetics, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.
Agnieszka PollakDepartment of Medical Genetics, Medical University of Warsaw, 02-106 Warsaw, Poland.ORCID 0000-0002-2847-1782
Karolina RutkowskaDepartment of Medical Genetics, Medical University of Warsaw, 02-106 Warsaw, Poland.
Jędrzej SarneckiDepartment of Diagnostic Imaging, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.ORCID 0000-0001-8325-2841
Lidia ZiółkowskaDepartment of Cardiology, The Children's Memorial Health Institute, 04-730 Warsaw, Poland.ORCID 0000-0003-0300-1941
Children's Memorial Health Institute · PLMedical University of Warsaw · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeft ventricular noncompaction cardiomyopathy (LVNC) is a rare cardiac disorder characterised by the presence of a two-layer myocardium with prominent ventricular trabeculation, intertrabecular deep depressions and an increased risk of heart failure, atrial and ventricular arrhythmias and systemic thromboembolic events in affected patients. The heterogeneous molecular aetiology solved in 10%-50% of patients more frequently involves sarcomeric, cytoskeletal or ion channel protein dysfunction-mainly related to causative

methodsThirty-one paediatric patients prospectively diagnosed with LVNC by echocardiography and cardiovascular magnetic resonance examination were recruited into the study group. The molecular analysis included next-generation sequencing (gene panel or whole exome) and classic Sanger sequencing. All selected variants with high priority were co-segregated in the available parents.

resultsWe identified 16 distinct variants in 11 genes in 16 patients (52%), including 10 novel alterations. The most frequent defects in our cohort were found in the genes

conclusionThis study expands the genetic and clinical spectrum of childhood LVNC. Although the molecular aetiology of LVNC varies widely, the comprehensive testing of a wide panel of cardiomyopathy-related genes helped to identify underlying molecular defects in more than half of the children in the study group. The molecular spectrum in our cohort correlated with the occurrence of arrhythmia, death and a family history of cardiomyopathy. We confirmed that genetic testing is an integral part of the work-up and management LVNC in children.

Indexed as

CardiomyopathiesHeart FailureArrhythmias, CardiacChildContrast MediaGadoliniumGenetic ProfileHumansSyndromeContrast MediaGadoliniumarrhythmiacardiomyopathychildrenheart failureleft ventricular noncompactionmolecular etiologynext generation sequencing

Identifiers

PMID35893073
PMCPMC9332142
OpenAlexW4288038637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.